Concepedia

Viera Hančinová

VH

Statistics

Publications

3

Citations

1.2K

H-Index

3

Active since

2014

Affiliations

Université de Lille(Current)

NeuroRx Research (Canada)

McGill University

Cleveland Clinic

Centre Hospitalier Universitaire de Lille

Viera Hančinová is an author at Université de Lille specializing in multiple sclerosis, neurology, and medicine.

Top concepts

MedicineNeurologyMultiple SclerosisClinical TrialsNeuroimmunologyHealthAllergyInflammationNeuromonitoringPharmacotherapy

Publications per year

2014–2021

3

Publications

3

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial

Daniel S. Reich, Douglas L. Arnold, Patrick Vermersch et al. · The Lancet Neurology · 2021 · 177 citations · Full text

Neurological Disorder, Phase 2B, Clinical Trials +7

Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis

Martin Karlík, Peter Valkovič, Viera Hančinová et al. · Clinical Biochemistry · 2014 · 82 citations

Inflammation, Allergy, Neurological Disorder +5

Rows per page

1–3 of 3